Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Int J Gynecol Cancer. 2021 Jun 16;31(7):1052–1060. doi: 10.1136/ijgc-2021-002674

Table 3:

Selected MDASI responses by opioid prescribing cohort on date of discharge and at post-discharge day 7

MDASI symptom measure Date of discharge Post-hospital discharge day 7
Pre-implementation Post-implementation P-value Pre-implementation Post-implementation P-value
N Mean ±SD N Mean ± SD N Mean ± SD N Mean ± SD
Pain 91 4.93 ± 2.6 155 5.14 ± 2.54 .53 88 3.18 ± 2.65 139 3.24 ± 2.26 .44
Fatigue 91 4.22 ± 2.82 155 4.31 ± 2.76 .98 88 3.24 ± 2.47 139 3.24 ± 2.25 .77
Nausea 91 1.57 ± 2.71 155 1.21 ± 2.02 .94 88 .81 ± 2.04 138 .34 ± .91 .59
Disturbed sleep 91 3.26 ± 3.44 155 3.7 ± 3.11 .19 88 2.31 ± 2.48 139 2.65 ± 2.44 .19
Drowsiness 91 3.44 ± 3.04 155 3.57 ± 2.8 .59 87 1.55 ± 1.94 139 1.54 ± 1.74 .85
Lack of appetite 91 3.03 ± 3.03 155 3.19 ± 3.05 .71 88 1.8 ± 2.06 139 1.45 ± 1.99 .12
Distress 91 1.66 ± 2.63 155 1.6 ± 2.38 .61 88 1.74 ± 2.47 138 1.35 ± 1.88 .62
Constipation 87 2.59 ± 3.25 153 3.4 ± 3.88 .26 86 1.48 ± 2.47 137 1.24 ± 2.16 .37
Abdominal bloating 37 3.14 ± 2.81 155 4.32 ± 2.99 .034 32 1.84 ± 1.9 139 2.46 ± 2.18 .13
Difficulty urinating 36 .14 ± .83 153 .51 ± 1.59 .045 32 .25 ± .8 138 .49 ± 1.48 .48
Walking 91 3.19 ± 2.99 155 3.43 ± 3.01 .53 87 2.59 ± 2.25 139 2.63 ± 2.58 .8
REM 91 2.23 ± 2.64 155 2.37 ± 2.42 .39 87 1.93 ± 2.14 139 1.89 ± 2.06 1.0
WAW 91 4.99 ± 2.93 155 4.92 ± 2.89 .86 87 4.04 ± 2.49 139 3.94 ± 2.69 .79

Significant p-values signified in bold text

MDASI = MD Anderson Symptom Inventory; SD=standard deviation; REM = relations with others, enjoyment of life, and mood; WAW=walking, general activity, and work